Dachaigh › Nephritis Lupus
Sgrùdaidhean clionaigeach Nephritis Lupus a’ fastadh anns na SA
Tha 33 sgrùdaidhean airson Nephritis Lupus a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- New York City, NY10 sgrùdaidhean
- Atlanta, GA9 sgrùdaidhean
- Chicago, IL9 sgrùdaidhean
- Houston, TX8 sgrùdaidhean
- Durham, NC8 sgrùdaidhean
- San Francisco, CA7 sgrùdaidhean
- Philadelphia, PA7 sgrùdaidhean
- Boston, MA7 sgrùdaidhean
- Miami, FL5 sgrùdaidhean
- Aurora, CO5 sgrùdaidhean
- St. Louis, MO5 sgrùdaidhean
- Dallas, TX4 sgrùdaidhean
- Charleston, SC4 sgrùdaidhean
- Los Angeles, CA4 sgrùdaidhean
- Cleveland, OH4 sgrùdaidhean
- Charlotte, NC4 sgrùdaidhean
- Syracuse, NY4 sgrùdaidhean
- Gainesville, FL3 sgrùdaidhean
- Santa Monica, CA3 sgrùdaidhean
- Columbus, OH3 sgrùdaidhean
- Johns Creek, GA3 sgrùdaidhean
- Worcester, MA3 sgrùdaidhean
- Jacksonville, FL3 sgrùdaidhean
- New Orleans, LA3 sgrùdaidhean
- Baltimore, MD3 sgrùdaidhean
- Washington, DC3 sgrùdaidhean
Le stàit
- Arizona3 sgrùdaidhean
- California15 sgrùdaidhean
- Colorado7 sgrùdaidhean
- Florida11 sgrùdadh
- Georgia11 sgrùdadh
- Illinois9 sgrùdaidhean
- Kansas3 sgrùdaidhean
- Louisiana5 sgrùdaidhean
- Maryland5 sgrùdaidhean
- Massachusetts8 sgrùdaidhean
- Michigan3 sgrùdaidhean
- Minnesota3 sgrùdaidhean
- Missouri6 sgrùdaidhean
- New Jersey5 sgrùdaidhean
- New York16 sgrùdaidhean
- North Carolina11 sgrùdadh
- Ohio7 sgrùdaidhean
- Pennsylvania7 sgrùdaidhean
- South Carolina5 sgrùdaidhean
- Tennessee4 sgrùdaidhean
- Texas12 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
A’ fastadhÌre 2
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT05268289A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
A’ fastadhÌre 2
Aoisean 16 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06419205Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
A’ fastadhÌre 3
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06711887CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
A’ fastadhÌre 1/2
Aoisean 10 gu 29 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06839976A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
A’ fastadhÌre 2
Aoisean 16 gu 70 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07328581VIBRANT: VIB4920 for Active Lupus Nephritis
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT05201469Study of Systemic Lupus Erythematosus
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 3 gu 120 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT00001372A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
A’ fastadhÌre 2
Aoisean 12 gu 70 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07570862Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
A’ fastadhÌre 1
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06975787The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
A’ fastadhÌre 2
Aoisean 8 gu 20 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT05538208A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
A’ fastadhÌre 1/2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
A’ fastadhÌre 1
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT07085104A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
A’ fastadhÌre 2
Aoisean 5 gu 17 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT05039619A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
A’ fastadhÌre 1
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT06925542RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
A’ fastadhÌre 1/2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06121297Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
A’ fastadhÌre 2
Aoisean 12 gu 65 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT07053800PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
A’ fastadhÌre 4
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT07611214A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT07201129Wellness & Workforce Solution for Lupus/Lupus Nephritis
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 24 Iuch 2026 · NCT06217107A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Iuch 2026 · NCT07115745Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT06527872US Zamto-cel Autoimmune Diseases
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Ògmh 2026 · NCT06708845A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
A’ fastadhÌre 1/2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT06557265Dapagliflozin in Active Lupus Nephritis
A’ fastadhÌre 4
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 26 Cèit 2026 · NCT07323524A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
A’ fastadhÌre 1
Aoisean 12 gu 70 · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT06308978Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.